Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:recombinant_factor_VIII
|
| gptkbp:clinical_trial |
Phase III trials
|
| gptkbp:dosage_form |
lyophilized powder
|
| gptkbp:effective_date |
2015-12-01
|
| https://www.w3.org/2000/01/rdf-schema#label |
Adynovate
|
| gptkbp:indication |
prophylaxis of bleeding episodes
|
| gptkbp:ingredients |
gptkb:octocog_alfa
|
| gptkbp:manufacturer |
gptkb:Baxter_International
|
| gptkbp:route_of_administration |
intravenous
|
| gptkbp:storage |
refrigerated
|
| gptkbp:used_for |
treatment of hemophilia A
|
| gptkbp:bfsParent |
gptkb:Shire_plc
|
| gptkbp:bfsLayer |
5
|